共 50 条
- [41] Annual indirect cost savings associated with galcanezumab versus placebo in patients with migraine: Post hoc analysis of phase 3 clinical trials HEADACHE, 2022, 62 : 102 - 103
- [43] Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials HEADACHE, 2019, 59 (06): : 880 - 890
- [45] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised clinical trials and post-hoc efficacy analysis (vol 19, pg 988, 2019) LANCET INFECTIOUS DISEASES, 2020, 20 (01): : E1 - E1
- [50] Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S746 - S747